Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells is a research paper published in Frontiers in Pharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U01 CA244303
NIGMS NIH HHS
Grant: R01 GM132261
NCI NIH HHS
Grant: R01 CA227479
NCI NIH HHS
Grant: R01 CA259111
National Institutes of Health
Grant: 5U01CA244303-05
Role of O-GlcNAcome on Breast Cancer Initiating Cells
National Institutes of Health
Grant: 1R01CA259111-01
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer
National Institutes of Health
Grant: 1R01GM132261-01A1
Quantification of compartmentalized metabolism in eukaryotic systems
National Institutes of Health
Grant: 5R01GM132261-04
Quantification of compartmentalized metabolism in eukaryotic systems
FWCI
3.56
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals